文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

高场术中磁共振成像引导下多形性胶质母细胞瘤手术中肿瘤体积切除程度与患者生存的相关性。

Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance.

机构信息

Department of Neurosurgery, University of Marburg, Marburg, Germany.

出版信息

Neuro Oncol. 2011 Dec;13(12):1339-48. doi: 10.1093/neuonc/nor133. Epub 2011 Sep 12.


DOI:10.1093/neuonc/nor133
PMID:21914639
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3223093/
Abstract

Extent of resection (EOR) still remains controversial in therapy of glioblastoma multiforme (GBM). However, an increasing number of studies favor maximum EOR as being associated with longer patient survival. One hundred thirty-five GBM patients underwent tumor resection aided by 1.5T intraoperative MRI (iMRI) and integrated multimodal navigation. Tumor volume was quantified by manual segmentation. The influences of EOR, patient age, recurrent tumor, tumor localization, and gender on survival time were examined. Intraoperative MRI detected residual tumor volume in 88 patients. In 19 patients surgery was continued; further resection resulted in final gross total resection (GTR) for 9 patients (GTR increased from 47 [34.80%] to 56 [41.49%] patients). Tumor volumes were significantly reduced from 34.25 ± 23.68% (first iMRI) to 1.22 ± 16.24% (final iMRI). According to Kaplan-Meier estimates, median survival was 14 months (95% confidence interval [CI]: 11.7-16.2) for EOR ≥ 98% and 9 months (95% CI: 7.4-10.5) for EOR <98% (P< .0001); it was 9 months (95% CI: 7.3-10.7) for patients ≥ 65 years and 12 months (95% CI: 8.4-15.6) for patients <65 years (P < .05). Multivariate analysis showed a hazard ratio of 0.39 (95% CI: 0.24-0.63; P = .001) for EOR ≥ 98% and 0.61 (95% CI: 0.38-0.97; P < .05) for patient age <65 years. To our knowledge, this is the largest study including correlation of iMRI, tumor volumetry, and survival time. We demonstrate that navigation guidance and iMRI significantly contribute to optimal EOR with low postoperative morbidity, where EOR ≥ 98% and patient age <65 years are associated with significant survival advantages. Thus, maximum EOR should be the surgical goal in GBM surgery while preserving neurological function.

摘要

在多形性胶质母细胞瘤(GBM)的治疗中,最大限度切除肿瘤(EOR)仍然存在争议。然而,越来越多的研究倾向于最大限度地切除肿瘤,因为这与患者生存时间延长有关。135 名 GBM 患者接受了 1.5T 术中磁共振成像(iMRI)和集成多模态导航辅助下的肿瘤切除术。通过手动分割来量化肿瘤体积。检查了 EOR、患者年龄、复发性肿瘤、肿瘤定位和性别对生存时间的影响。术中 MRI 检测到 88 名患者的残余肿瘤体积。在 19 名患者中继续进行手术;进一步切除导致最终大体全切除(GTR)的患者有 9 名(GTR 从 47 [34.80%]增加到 56 [41.49%])。肿瘤体积从 34.25±23.68%(首次 iMRI)显著减少至 1.22±16.24%(最终 iMRI)。根据 Kaplan-Meier 估计,EOR≥98%的中位生存时间为 14 个月(95%CI:11.7-16.2),EOR<98%的中位生存时间为 9 个月(95%CI:7.4-10.5)(P<.0001);年龄≥65 岁的患者中位生存时间为 9 个月(95%CI:7.3-10.7),年龄<65 岁的患者中位生存时间为 12 个月(95%CI:8.4-15.6)(P <.05)。多变量分析显示,EOR≥98%的危险比为 0.39(95%CI:0.24-0.63;P=.001),年龄<65 岁的危险比为 0.61(95%CI:0.38-0.97;P<.05)。据我们所知,这是最大的研究,包括 iMRI、肿瘤体积测量和生存时间的相关性。我们证明导航引导和 iMRI 显著有助于实现最佳 EOR,同时术后发病率低,EOR≥98%和患者年龄<65 岁与显著的生存优势相关。因此,在保留神经功能的情况下,最大限度地切除肿瘤应成为 GBM 手术的目标。

相似文献

[1]
Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance.

Neuro Oncol. 2011-9-12

[2]
Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery.

Eur J Surg Oncol. 2013-12-19

[3]
Volumetric Analysis Using Low-Field Intraoperative Magnetic Resonance Imaging for 168 Newly Diagnosed Supratentorial Glioblastomas: Effects of Extent of Resection and Residual Tumor Volume on Survival and Recurrence.

World Neurosurg. 2017-2

[4]
Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival.

PLoS One. 2015-6-26

[5]
Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma.

Neuro Oncol. 2013-11-26

[6]
Glioblastoma surgery with and without intraoperative MRI at 3.0T.

Neurochirurgie. 2014-8

[7]
[Application of intraoperative magnetic resonance imaging and multimodal navigation in surgical resection of glioblastoma].

Zhonghua Wai Ke Za Zhi. 2013-6-1

[8]
The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?

J Neurosurg. 2016-4

[9]
Dual-Use Intraoperative MRI in Glioblastoma Surgery: Results of Resection, Histopathologic Assessment, and Surgical Site Infections.

J Neurol Surg A Cent Eur Neurosurg. 2019-11

[10]
The effects of new or worsened postoperative neurological deficits on survival of patients with glioblastoma.

J Neurosurg. 2016-9-30

引用本文的文献

[1]
Cystic glioblastoma IDH-wildtype: genetic alterations and outcomes.

J Neurooncol. 2025-7-3

[2]
Intraoperative Fast Adaptive Focus Tracking Robotic OCT Enables Real-Time Tumor Grading and Large-Area Microvascular Imaging in Human Spinal Cord Surgery.

Adv Sci (Weinh). 2025-7

[3]
HOTAIR expression as a biomarker in glioblastoma multiforme: a comprehensive meta-analysis of current evidence.

Biomark Med. 2025-2

[4]
Radiological and Not Clinical Variables Guide the Surgical Plan in Patients with Glioblastoma.

Curr Oncol. 2024-4-1

[5]
Brain tumor grading diagnosis using transfer learning based on optical coherence tomography.

Biomed Opt Express. 2024-3-13

[6]
A comparative study of diffusion kurtosis imaging and diffusion tensor imaging in detecting corticospinal tract impairment in diffuse glioma patients.

Neuroradiology. 2024-5

[7]
Advancements in Glioma Care: Focus on Emerging Neurosurgical Techniques.

Biomedicines. 2023-12-20

[8]
Glioma: bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy.

Front Immunol. 2024-1-11

[9]
Novel Therapies in Glioblastoma Treatment: Review of Glioblastoma; Current Treatment Options; and Novel Oncolytic Viral Therapies.

Med Sci (Basel). 2023-12-23

[10]
A Wearable Fluorescence Imaging Device for Intraoperative Identification of Human Brain Tumors.

IEEE J Transl Eng Health Med. 2024

本文引用的文献

[1]
Intraoperative mapping and monitoring of the corticospinal tracts with neurophysiological assessment and 3-dimensional ultrasonography-based navigation. Clinical article.

J Neurosurg. 2010-8-27

[2]
Low field intraoperative MRI-guided surgery of gliomas: a single center experience.

Clin Neurol Neurosurg. 2010-4

[3]
Impact of intraoperative high-field magnetic resonance imaging guidance on glioma surgery: a prospective volumetric analysis.

Neurosurgery. 2009-6

[4]
Updating navigation with intraoperative image data.

Top Magn Reson Imaging. 2009-1

[5]
Independent association of extent of resection with survival in patients with malignant brain astrocytoma.

J Neurosurg. 2009-1

[6]
Glioma extent of resection and its impact on patient outcome.

Neurosurgery. 2008-4

[7]
Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias.

Neurosurgery. 2008-3

[8]
Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas.

J Clin Oncol. 2008-3-10

[9]
Cortical and subcortical motor mapping in rolandic and perirolandic glioma surgery: impact on postoperative morbidity and extent of resection.

J Neurosurg Sci. 2007-6

[10]
Is the image guidance of ultrasonography beneficial for neurosurgical routine?

Surg Neurol. 2007-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索